N10 Assets LLC Acquires Shares of 13,808 Axon Enterprise, Inc $AXON

N10 Assets LLC acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 13,808 shares of the biotechnology company’s stock, valued at approximately $7,741,000. Axon Enterprise makes up approximately 3.3% of N10 Assets LLC’s holdings, making the stock its 12th largest position.

A number of other large investors have also recently made changes to their positions in the business. Evergreen Capital Management LLC grew its position in Axon Enterprise by 3.8% in the second quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock worth $342,000 after acquiring an additional 15 shares in the last quarter. Synergy Financial Group LTD boosted its holdings in shares of Axon Enterprise by 1.4% in the 3rd quarter. Synergy Financial Group LTD now owns 1,388 shares of the biotechnology company’s stock worth $996,000 after purchasing an additional 19 shares during the period. Tower Research Capital LLC TRC boosted its holdings in shares of Axon Enterprise by 1.2% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,631 shares of the biotechnology company’s stock worth $1,350,000 after purchasing an additional 19 shares during the period. Certuity LLC boosted its holdings in shares of Axon Enterprise by 5.1% in the 4th quarter. Certuity LLC now owns 474 shares of the biotechnology company’s stock worth $269,000 after purchasing an additional 23 shares during the period. Finally, Pure Financial Advisors LLC increased its position in shares of Axon Enterprise by 6.7% during the 4th quarter. Pure Financial Advisors LLC now owns 364 shares of the biotechnology company’s stock valued at $207,000 after purchasing an additional 23 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 13,000 shares of the company’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $488.45, for a total value of $6,349,850.00. Following the transaction, the president directly owned 169,125 shares in the company, valued at $82,609,106.25. This represents a 7.14% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jeffrey C. Kunins sold 9,605 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the transaction, the insider directly owned 97,761 shares in the company, valued at approximately $61,266,818.70. This trade represents a 8.95% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 76,594 shares of company stock valued at $41,236,386. Company insiders own 4.20% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. JPMorgan Chase & Co. increased their price target on Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. TD Cowen reiterated a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, July 22nd. UBS Group increased their target price on shares of Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Royal Bank Of Canada restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, July 21st. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a research note on Wednesday, August 5th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $730.92.

Axon Enterprise Price Performance

AXON opened at $611.20 on Friday. The business has a fifty day moving average of $557.20 and a 200 day moving average of $482.16. Axon Enterprise, Inc has a 52-week low of $339.01 and a 52-week high of $794.29. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. The stock has a market cap of $49.65 billion, a P/E ratio of 253.61, a PEG ratio of 9.86 and a beta of 1.39.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The company had revenue of $904.39 million for the quarter, compared to the consensus estimate of $876.42 million. During the same quarter in the prior year, the company posted $2.12 EPS. Axon Enterprise’s quarterly revenue was up 35.3% on a year-over-year basis. As a group, sell-side analysts anticipate that Axon Enterprise, Inc will post 2.04 EPS for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.